NCT07491185 Effect of Glycemic Control on Intraoperative NIRS and Postoperative Recovery in Diabetic Patients
| NCT ID | NCT07491185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ege University |
| Condition | Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-11-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to evaluate the effect of glycemic control level on intraoperative cerebral oxygenation measured by near-infrared spectroscopy (NIRS) and postoperative recovery in patients with diabetes mellitus undergoing elective urologic surgery under general anesthesia. Patients will be grouped according to HbA1c levels to assess the relationship between long-term glycemic control and intraoperative regional cerebral oxygen saturation, hemodynamic parameters, and postoperative recovery scores.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Patients scheduled for elective urologic surgery under general anesthesia * ASA physical status I-III * Patients with diabetes mellitus or non-diabetic control patients * Availability of preoperative HbA1c measurement * Written informed consent obtained Exclusion Criteria: * Age \<18 years * ASA physical status \>III * Emergency surgery * History of cerebrovascular disease or neurological disorder * Previous brain or neurological surgery * Inability to communicate or refusal to participate * Intraoperative hemodynamic instability * Inadequate NIRS monitoring data
Contact & Investigator
NURSEN KARACA, MD
PRINCIPAL INVESTIGATOR
Ege University
Frequently Asked Questions
Who can join the NCT07491185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07491185 currently recruiting?
Yes, NCT07491185 is actively recruiting participants. Contact the research team at dr.nursenkaraca@hotmail.com for enrollment information.
Where is the NCT07491185 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07491185 clinical trial?
NCT07491185 is sponsored by Ege University. The principal investigator is NURSEN KARACA, MD at Ege University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.